The Discounted Cash Flow (DCF) valuation of ANI Pharmaceuticals Inc (ANIP) is 73.13 USD. With the latest stock price at 59.16 USD, the upside of ANI Pharmaceuticals Inc based on DCF is 23.6%.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.1% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 39.05 - 206.23 | 73.13 |
| Upside | -34.0% - 248.6% | 23.6% |